NeoPharm Co. Ltd. (092730.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 287.03B |
| Enterprise Value | 262.12B |
| P/E Ratio | 11.58 |
| PEG Ratio | 0.56 |
| Price/Sales Ratio | 2.38 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 2.17 |
| Enterprise/EBITDA | 8.22 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.21 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 132.18B |
| Revenue/Share | 9,257.99 |
| Gross Profit | 84.71B |
| EBITDA | 31.88B |
| Net Income | 27.91B |
| Diluted EPS | 1,778.81 |
Balance Sheet
| Total Cash | 147.59B |
| Total Cash/Share | 9,208.23 |
| Total Debt | 1.65B |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.75 |
| Book Value Per Share | 11,985.68 |
Price History
| 52-Week Change | 17.51 |
| 52-Week High | 26,000 |
| 52-Week Low | 15,590 |
| Moving Average 50 Days | 19,355.2 |
| Moving Average 200 Days | 18,789.1 |
Statistics
| Average Volume | 60,249 |
| Shares Outstanding | 15.64M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 600 |
| Trailing Annual Dividend Yield | 2.66 |
| Payout Ratio | 0.31 |
| Last Split Factor | 2:1 |
| Last Split Date | October 30, 2024 |
AD
